• CME Group has already launched 24/7 trading for its cryptocurrency futures and options, including Bitcoin Volatility futures, giving global market participants continuous access to regulated crypto risk management tools and aligning listed derivatives with the always-on nature of digital asset markets.
• Over the first weekend of round-the-clock trading, more than 7,200 crypto futures and options contracts changed hands, about US$50.00 million in notional value, highlighting immediate liquidity and broad participation from both retail and institutional users.
• Now we’ll examine how always-on crypto derivatives trading, including Bitcoin Volatility futures, could influence CME Group’s longer-term investment narrative.

Outshine the giants: these 12 early-stage AI stocks could fund your retirement.

CME Group Investment Narrative Recap

To own CME Group, you need to believe in the durability of global derivatives trading across asset classes and the company’s ability to keep adding useful, fee‑generating products. The move to 24/7 crypto derivatives trading, including Bitcoin Volatility futures, reinforces its role in regulated digital assets, but does not fundamentally change that the key near term catalyst remains overall volume growth, while a major ongoing risk is structural competition from alternative trading venues and DeFi.

The most relevant recent announcement here is CME’s record Q1 2026 results, with all‑time high average daily volume of 36.2 million contracts and an adjusted operating margin of 72.8%. Against that backdrop, the early uptake in always‑on crypto trading and new volatility products sits alongside broader interest rate, equity index and data franchises that continue to anchor the business, even as emerging technologies and new market structures test the limits of centralized exchanges.

Yet investors should be aware that rising DeFi adoption and alternative venues could, over time, chip away at CME’s core trading franchise and...

CME Group's narrative projects $7.8 billion revenue and $4.6 billion earnings by 2029. This requires 5.1% yearly revenue growth and about a $0.4 billion earnings increase from $4.2 billion today.

Uncover how CME Group's forecasts yield a $306.60 fair value, a 19% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$246 to US$307 per share, reflecting a wide spread of individual views. Against this range, CME’s push into 24/7 crypto derivatives trading highlights how product innovation might influence future volumes and fee resilience, which readers may want to weigh alongside these differing valuation perspectives.

Explore 4 other fair value estimates on CME Group - why the stock might be worth just $246.24!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your CME Group research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free CME Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CME Group's overall financial health at a glance.

Ready For A Different Approach?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Capitalize on the AI infrastructure supercycle with our selection of the 47 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.